Overview of the cancer website, detailing the articles about types of malignancies, symptoms of the disease, and available treatment options.

Gallbladder Cancer - Signs, Symptoms and Treatment

Gallbladder cancer refers to a malignant tumor afflicting the human gallbladder.  This is the pear-shaped organ which stores the substance known as bile.  Bile is the greenish liquid that the liver's cells produce to aid in digesting fats.  A tumor forms when cells in the gallbladder experience abnormal, out-of-control growth.  This tumor is said to be benign if it does not invade nearby tissue or travel throughout the body.  In this case, the tumor is much less serious than if it's malignant, i.e., it invades nearby tissue and has the ability of travelling to other parts of the body.  This malignant tumor is what's known as gallbladder cancer.  It's most commonly found in older people, with the median age for the disease being age 62 to 66.  More patients are female than male, by a 3 to 1 radio. 

Nobody knows the exact cause of gallbladder cancer, however it has been linked with gallstones, cigarette smoking, high levels of estrogen, alcohol, and obesity.  A staggering number 70 to 90 percent of gallbladder-cancer victims have gallstones.  However, don't make the mistake of thinking that because you get gallstones, you're going to get cancer.  The vast majority of people with gallstones never get gallbladder cancer.

It's difficult to detect symptoms of gallbladder cancer.  Some of the symptom tend to be jaundice, weight loss and loss of appetite.  Sometimes there's pain in the abdomen, particularly under the right-side rib cage.  Because there are no good, clear symptoms of the disease, most people are diagnosed with gallbladder cancer by a surgeon who is removing the gallbladder, usually for some unrelated reason.  In most cases, the signal to the doctor that gallbladder cancer might be present is a skin jaundice or jaundice of the whites of the person's eyes, or perhaps a mass in the present in the upper right abdominal quadrant or surrounding the navel.

The stages of gallbladder cancer's primary tumor run like this:  In TX stage, the main tumor can't be assessed.  In TD, there's no evidence of the min tumor.  In Tis, there is carcinoma present in situ.  In T1, the tumor will invade muscle layer.  In T2, it invades the perimuscular connective tissue.  In T3, it begins invading the serosa or the liver and possibly other adjacent structures / organs.  In T4, it begins invading the hepatic artery or main portal vein or possibly other adjacent organs.

Treatment of gallbladder tumors typically involves several methods combined together to help the patient.  If the cancer is caught in the early stages, the doctors often consider surgery alone.  Re-excision is the recommended approach if a gallbladder cancer is discovered during a cholecystectomy and if the disease is in stage 2 or above.  In stage 1, there is often much controversy as to whether re-excision should be considered.  Complete removal of all tumor through surgery is the only actually "curative" method of treating the cancer. 

It's unfortunate that only around 25 percent of patients who have the disease are able to be treated with definitive surgery.  Also, the surgery is normally quite extensive, and will involve removing the gallbladder, lymph nodes in the region, as well as a part of the liver if doctors determine there is a possibility of invasion.  Even in cases where surgery is possible, the doctor is often not able to make major resection margins in the tumor's perimeter, which means that malignant cells could exist close to tissue edges where the doctor cuts.  This means that there is a high chance of recurrence of the tumor.  For this reason, if there is doubt about getting all of the tumor, sometimes radiation therapy is used in an effort to eradicate all microscopic cancer in the area of surgery.

Catching cancer early is always important, and this holds true also of gallbladder cancer.  Of those patients who are diagnosed in stage 1, there is a 70 to 85 percent five-year survival rate.  For those caught in stage 2, it drops significantly to 25 percent.  In stage 3, it's 12 percent, and in stage 4, only one to two percent.